Persistent URL of this record https://hdl.handle.net/1887/108018
In Collections
This item can be found in the following collections:
![A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-alpha 2b in patients with recurrent epithelial ovarian cancer](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-alpha 2b in patients with recurrent epithelial ovarian cancer
- All authors
- Dijkgraaf, E.M.; Santegoets, S.J.A.M.; Reyners, A.K.L.; Goedemans, R.; Wouters, M.C.A.; Kenter, G.G.; Erkel, A.R. van; Poelgeest, M.I.E. van; Nijman, H.W.; Hoeven, J.J.M. van der; Welters, M.J.P.; Burg, S.H. van der; Kroep, J.R.
- Date
- 2015-10-31
- Journal
- Annals of Oncology
- Volume
- 26
- Issue
- 10
- Pages
- 2141 - 2149